Specialty Coating Systems has announced a significant breakthrough in Parylene coating technologies: SCS microRESIST Antimicrobial Parylene Technology. SCS microRESIST combines the benefits of biocompatible Parylene with antimicrobial properties to effectively eliminate harmful microorganisms on coated medical devices. As healthcare-associated infections (HAIs) increase and continue to pose a challenge to hospitals and healthcare facilities, providers are tasked with improving patient health while reducing the risk of infection. SCS provides a new solution by offering manufacturers antimicrobial coating technology that effectively eliminates microorganisms.
Testing per JIS Z 2801, SCS microRESIST has demonstrated greater than 5 Log reduction after 24 hours on 14 common microorganisms, including E. coli and Staphylococcus aureus. The coating technology has also been tested for long-term effectiveness against E. coli, and achieved greater than 5 Log reduction. SCS microRESIST technology can be applied to a variety of medical devices and applications, including catheters, electro-stimulators, endotracheal tubes and other medical devices where antimicrobial properties are critical during a product’s use.
For more information, visit www.scscoatings.com.